Cite
MLA Citation
Fatma Beyazit et al.. “Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.” Medical hypotheses, vol. 143, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100110822126.0x000042